SEC 13F Intelligence

Enhancing Capital LLC / LLY

Enhancing Capital LLC’s Eli Lilly & Co Position

Does Enhancing Capital LLC own Eli Lilly & Co (LLY)? Yes8.3K shares worth $8M (+5.66% of its 13F portfolio) as of Q1 2026.

Position Value
$8M
Q1 2026
Shares
8.3K
% of Portfolio
+5.66%
Quarters Held
10
currently held

Position History LLY

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q1 ’22: $2MQ2 ’22: $3MQ2 ’22Q3 ’22: $3MQ4 ’24: $6MQ4 ’24Q1 ’25: $7MQ2 ’25: $6MQ2 ’25Q3 ’25: $6MQ4 ’25: $9MQ4 ’25Q1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20268.3K$8M+5.66%
Q4 20258.3K$9M+6.38%
Q3 20258.3K$6M+4.63%
Q2 20258.3K$6M+4.93%
Q1 20258.3K$7M+5.48%
Q4 20248.3K$6M+5.11%
Q3 20228.3K$3M+3.35%
Q2 20228.3K$3M+3.21%
Q1 20228.3K$2M+2.54%
Q4 20218.3K$2M+2.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enhancing Capital LLC’s full portfolio or all institutional holders of LLY.